Trials / Unknown
UnknownNCT02328209
Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration
Evaluation of the Efficacy and Continuance Rate of Treatment in Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Mie University · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Recently studies have shown that intravitreal injection of ranibizumab is effective for age related macular degeneration. However there are problems about injection regimen of maintenance phase. We plan to perform new simplified treat and extend regimen using ranibizumab.
Detailed description
The purpose of the present study is to evaluate the simplified treat and extend regimen using ranibizumab in eyes with wet age related macular degeneration about best-corrected visual acuity, central retinal thickness, the disappearance rate of the morphological change and treatment continuous rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ranibizumab | 0.5mg/0.05ml, intravitreal injection, frequency: each 8 or 12 weeks |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2014-12-31
- Last updated
- 2014-12-31
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02328209. Inclusion in this directory is not an endorsement.